ConductScience.org, home

Paper11533489

Duration of nuclear NF-kappaB action regulated by reversible acetylation.

Chen Lf and 3 others. Science, 2001. Cited by 1,053 papers, by iCite.

Cite this record

ConductScience Library. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Papers, record 11533489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11533489

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Duration of nuclear NF-kappaB action regulated by reversible acetylation.
PubMed
Journal
Science
PubMed
Year
2001
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
1,053
iCite
Relative citation ratio, by iCite
19.1
iCite
Revised in PubMed
2026-01-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen Lf
2Fischle WW
3Verdin EE
4Greene WCW C

Source PubMed

Download CSV of authors

Topics34

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell NucleusMajor topic
I-kappa B ProteinsMajor topic
NF-kappa BMajor topic
Acetylation
Acetyltransferases
Active Transport, Cell Nucleus
Animals
COS Cells
CREB-Binding Protein
Cell Cycle Proteins
Cell Line
Cytoplasm
DNA
DNA-Binding Proteins
HeLa Cells
Histone Acetyltransferases
Histone Deacetylase Inhibitors
Histone Deacetylases
Humans
Hydroxamic Acids
Mice
NF-KappaB Inhibitor alpha
Nuclear Proteins
Phosphorylation
Protein Binding
Protein Transport
Recombinant Fusion Proteins
Trans-Activators
Transcription Factor RelA
Transcription Factors
Tumor Necrosis Factor-alpha
p300-CBP Transcription Factors
p300-CBP-Associated Factor
Histone Deacetylase 3

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30MH59037NIMH NIH HHSUnited StatesP30MH059037PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by555

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,053 citations.

PMIDTitleJournalYearIn PapersSource
42958367CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer.Mol Cancer2026https://conductscience.org/library/papers/42958367PubMed
42905243HDAC3 Inhibitor RGFP966 Enhances Memory Persistence in a Biphasic Manner and Modulates NF-kB Nuclear Localization.Mol Neurobiol2026https://conductscience.org/library/papers/42905243PubMed
42811655Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF-κB Deacetylation to Alleviate Ischemic Brain Injury.CNS Neurosci Ther2026https://conductscience.org/library/papers/42811655PubMed
42747207Cannabidiol Ameliorates Blood-Brain Barrier Dysfunction and Inhibits Memory Astrocytes Activation in Mice With Sickness-Like Behaviors.CNS Neurosci Ther2026https://conductscience.org/library/papers/42747207PubMed
42699205Metabolite-driven protein modifications in immune signaling: from established principles to emerging pyruvylation.Front Immunol2026https://conductscience.org/library/papers/42699205PubMed
42199440Metabolism-driven emerging acylation modifications in COPD: from elucidation of fundamental mechanisms to clinical diagnosis and treatment.Front Immunol2026https://conductscience.org/library/papers/42199440PubMed
42193094Natural Products Targeting Acetylation in Bladder Cancer: Mechanistic Basis, Therapeutic Potential, and Future Perspectives.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42193094PubMed
42183232Metabolic and post-translational modifications in sepsis-associated immune dysfunction: a conceptual framework.Front Immunol2026https://conductscience.org/library/papers/42183232PubMed
42148116The long noncoding RNA lnc-FAM164A1-ACLY axis promotes pro-inflammatory responses in human primary macrophages: a systems approach.Front Immunol2026https://conductscience.org/library/papers/42148116PubMed
42015143The roles of IKKα in normal physiology and cancer.Cell Commun Signal2026https://conductscience.org/library/papers/42015143PubMed
41749811NF-κB Signaling as a Central Driver of Cancer Cachexia.Cancers (Basel)2026https://conductscience.org/library/papers/41749811PubMed
41515997Oral and Gut Health, (Neuro) Inflammation, and Central Sensitization in Chronic Pain: A Narrative Review of Mechanisms, Treatment Opportunities, and Research Agenda.Int J Mol Sci2025https://conductscience.org/library/papers/41515997PubMed
41322258A novel RELA K119 deacetylation mediated by SIRT7 is a pivotal activator to exacerbate liver inflammation and fibrosis in teleosts.Mar Life Sci Technol2025https://conductscience.org/library/papers/41322258PubMed
41311406The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials.Acta Pharm Sin B2025https://conductscience.org/library/papers/41311406PubMed
41272697Cisplatin-mediated activation of NF-κB promotes lung cancer stem cell formation via DNA repair pathways.J Transl Med2025https://conductscience.org/library/papers/41272697PubMed
41236113NF-κB Is a Potential Therapeutic Target for Histone Deacetylase Inhibitor-Resistant Cutaneous T-Cell Lymphoma.Cancer Sci2026https://conductscience.org/library/papers/41236113PubMed
41225360Molecular regulatory mechanism of the SIRT2/NF-κB p65 signaling pathway in ferroptosis-promoted spinal cord injury repair.BMC Neurol2025https://conductscience.org/library/papers/41225360PubMed
41192481Sphingomyelin regulates astrocyte activity by regulating NF-κB signaling via HDAC1/3 expression.J Lipid Res2025https://conductscience.org/library/papers/41192481PubMed
40787446Short-chain fatty acids: key antiviral mediators of gut microbiota.Front Immunol2025https://conductscience.org/library/papers/40787446PubMed
40606622Protective effect of Salvianolic acid B against atherosclerosis: a preclinical systematic review and meta-analysis.Front Pharmacol2025https://conductscience.org/library/papers/40606622PubMed

See all 555 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
RELA5970Swiss-Prot's referenceshttps://conductscience.org/library/genes/5970NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
HDAC38841PubTator's text mininghttps://conductscience.org/library/genes/8841NCBI Gene
KAT2B8850PubTator's text mininghttps://conductscience.org/library/genes/8850NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
NFKBIA4792PubTator's text mininghttps://conductscience.org/library/genes/4792NCBI Gene
XPO17514PubTator's text mininghttps://conductscience.org/library/genes/7514NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/11533489

GET https://conductscience.org/api/papers/v1/11533489/cited_by?page=2